---
service: svc_regulatory_japan_pmda
modality: mod_biologics_other
site: cro
companies_count: 12
generated_by: BioBM Editorial AI
---

# Japan PMDA Regulatory Strategy × Biologics (Other)

Japan PMDA Regulatory Strategy combined with Biologics (Other) is a common shortlist filter for sponsors evaluating CRO partners. This explore page lists organizations that publicly map to both dimensions, so you can move from taxonomy browsing to a tighter candidate set without rebuilding filters from scratch.

Profiles here are fit-first: open each listing for scope, geography, regulatory posture, and provenance-backed facts. The directory does not rank these rows as a single "best" answer — use them to assemble a right-sized outreach list for your program stage and quality bar.

When you need adjacent criteria (indications, claim status, or cross-category search), continue to the main search experience and layer filters on top of this service × modality starting point.

## Matching companies

- [Aragen Life Sciences](/companies/aragen)
- [Certara](/companies/certara)
- [Fortrea](/companies/fortrea)
- [ICON](/companies/kcrcro)
- [IQVIA Real-World Solutions](/companies/iqvia)
- [Medpace](/companies/medpace)
- [Novotech](/companies/novotech-cro)
- [PPD](/companies/ppd)
- [Pharmaron](/companies/pharmaron)
- [Premier Research](/companies/premier-research)
- [Syngene International](/companies/syngeneintl)
- [WuXi AppTec](/companies/wuxiapptec)